| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |